20112020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020

Review article: determination of the therapeutic range for therapeutic drug monitoring of adalimumab and infliximab in patients with inflammatory bowel disease

Gibson, D. J., Ward, M. G., Rentsch, C., Friedman, A. B., Taylor, K. M., Sparrow, M. P. & Gibson, P. R., Mar 2020, In : Alimentary Pharmacology & Therapeutics. 51, 6, p. 612-628 17 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

2019

Comparison of Adalimumab Serum Drug Levels When Delivered by Pen Versus Syringe in Patients With Inflammatory Bowel Disease. An International, Multicentre Cohort Analysis

Little, R. D., Chu, I. E., van der Zanden, E. P., Flanagan, E., Bell, S. J., Gibson, P. R., Sparrow, M. P., Shelton, E., Connor, S. J., Roblin, X. & Ward, M. G., 10 Dec 2019, In : Journal of Crohn's and Colitis. 13, 12, p. 1527-1536 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Editorial: infliximab de-escalation in inflammatory bowel disease using a therapeutic drug monitoring strategy—early promise but more data needed

Gibson, D. J. & Ward, M. G., Mar 2019, In : Alimentary Pharmacology & Therapeutics. 49, 6, p. 816-817 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access
1 Citation (Scopus)
2018

Inadequate storage of subcutaneous biological agents by patients with inflammatory bowel disease: Another factor driving loss of response?

Rentsch, C., Headon, B., Ward, M. G. & Gibson, P. R., Jan 2018, In : Journal of Gastroenterology and Hepatology. 33, 1, p. 10-11 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access

Pharmacist-Led Proactive Therapeutic Drug Monitoring with Infliximab (Proximo): Utility of and Cost Saving Associated with the use of a Rapid Assay for Assessing Drug Level

Rentsch, C., Sparrow, M., Ward, M. G., Friedman, A., Taylor, K. M., Luber, R. P., Su, H. Y., Hopkins, R., Headon, B., Dooley, M. & Gibson, P. R., May 2018, In : Gastroenterology. 154, 6 (Suppl 1), p. S826-S286 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2017

Editorial: variability in adalimumab trough and peak serum concentrations – authors’ reply

Ward, M. G., Gibson, P. R. & Sparrow, M. P., 1 Jun 2017, In : Alimentary Pharmacology & Therapeutics. 45, 11, p. 1476-1477 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

Editorial: different tests for different drugs in Crohn’s disease, or different tests for different people? Authors’ reply

Ward, M. G. & Irving, P. M., Aug 2017, In : Alimentary Pharmacology & Therapeutics. 46, 4, p. 465 1 p.

Research output: Contribution to journalEditorialOtherpeer-review

Open Access

Infliximab and adalimumab drug levels in Crohn's disease: contrasting associations with disease activity and influencing factors

Ward, M. G., Warner, R. B., Unsworth, N., Chuah, S. W., Brownclarke, C., Shieh, S., Parkes, M., Sanderson, J. D., Arkir, Z., Reynolds, J., Gibson, P. R. & Irving, P. M., 1 Jul 2017, In : Alimentary Pharmacology & Therapeutics. 46, 2, p. 150-161 12 p.

Research output: Contribution to journalArticleResearchpeer-review

34 Citations (Scopus)

Intra-patient variability in adalimumab drug levels within and between cycles in Crohn's disease

Ward, M. G., Thwaites, P. A., Beswick, L., Hogg, A. J., Rosella, G., Van Langenberg, D., Reynolds, J., Gibson, P. R. & Sparrow, M. P., 1 Apr 2017, In : Alimentary Pharmacology & Therapeutics. 45, 8, p. 1135-1145 11 p.

Research output: Contribution to journalArticleResearchpeer-review

19 Citations (Scopus)

Is there a role for thioguanine therapy in IBD in 2017 and beyond?

Taylor, K. M., Ward, M. G., Blaker, P. A. & Sparrow, M. P., 4 May 2017, In : Expert Review of Gastroenterology & Hepatology. 11, 5, p. 473-486 14 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

8 Citations (Scopus)

Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases

IBD Sydney Organisation and the Australian Inflammatory Bowel Diseases Consensus Working Group, 1 Dec 2017, In : Alimentary Pharmacology & Therapeutics. 46, 11-12, p. 1037-1053 17 p.

Research output: Contribution to journalReview ArticleOtherpeer-review

91 Citations (Scopus)
2014

Editorial: Escalation to weekly dosing in adalimumab-treated patients with active ulcerative colitis

Ward, M. G. & Sparrow, M. P., Sep 2014, In : Alimentary Pharmacology & Therapeutics. 40, 6, p. 730-731 2 p.

Research output: Contribution to journalEditorialOtherpeer-review

2011

Colonic perforation during percutaneous endoscopic gastrostomy tube insertion with subsequent bumper migration into colon

Ward, M., Rees, C., Asthana, A. K. & Lubel, J. S., 2011, In : Clinical Gastroenterology and Hepatology. 9, 12, p. 128 - 128 1 p.

Research output: Contribution to journalArticleOther

1 Citation (Scopus)